EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Harnessing Microbiome, Bacterial Extracellular Vesicle, and Artificial Intelligence for Polycystic Ovary Syndrome Diagnosis and Management

Bhawna Kushawaha iD, Tial T Rem, Emanuele Pelosi iD

Biomolecules · 07.06.2025 · 15 (6) · 834

DOI: 10.3390/biom15060834 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 07.06.2025. Verfasst von Bhawna Kushawaha und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, Indiana University, Indianapolis, IN 46202, USA. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Artificial Intelligence, Extracellular Vesicles, Microbiota. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 159 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Polycystic ovary syndrome (PCOS) affects 6–19% of reproductive-age women worldwide, yet diagnosis remains challenging due to heterogeneous presentations and symptoms overlapping with other endocrine disorders. Recent studies have shown that gut dysbiosis plays a significant role in PCOS pathophysiology, with bacterial extracellular vesicles (BEVs) functioning as critical mediators of the gut–ovary axis. BEVs carry distinct cargos in PCOS patients—including specific miRNAs and inflammatory proteins—and show promise for both diagnostic and therapeutic applications. Artificial intelligence (AI) is emerging as a promising significant tool in PCOS research due to improved diagnostic accuracy and the capability to analyze complex datasets combining microbiome, BEV, and clinical parameters. These integrated approaches have the potential to better address PCOS multifactorial nature, enabling improved phenotypic classification and personalized treatment strategies. This review examines recent advances in the last 25 years in microbiome, BEV, and AI applications in PCOS research using PubMed, Web of Science, and Scopus databases. We explore the diagnostic potential of the AI-driven analysis of microbiome and BEV profiles, and address ethical considerations including data privacy and algorithmic bias. As these technologies continue to evolve, they hold increasing potential for the improvement of PCOS diagnosis and management, including the development of safer, more precise, and effective interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Ovary SyndromeArtificial IntelligenceExtracellular VesiclesMicrobiotaGastrointestinal MicrobiomeHumansFemaleDysbiosisBacteria

Stichwörter der Autor:innen

AI in PCOS diagnosticartificial intelligence (AI)bacterial extracellular vesicles (BEV)extracellular vesicles (EV)microbiomeovarypolycystic ovary syndrome (PCOS)

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular Biology, Indiana University, Indianapolis, IN 46202, USA.

ORCID-Profile: Bhawna Kushawaha, Emanuele Pelosi

Zitieren

APA

Kushawaha, B., Rem, T. T., & Pelosi, E. (2025). Harnessing Microbiome, Bacterial Extracellular Vesicle, and Artificial Intelligence for Polycystic Ovary Syndrome Diagnosis and Management. Biomolecules, 15(6), 834. https://doi.org/10.3390/biom15060834

Vancouver

Kushawaha B, Rem TT, Pelosi E. Harnessing Microbiome, Bacterial Extracellular Vesicle, and Artificial Intelligence for Polycystic Ovary Syndrome Diagnosis and Management. Biomolecules. 2025;15(6):834. doi:10.3390/biom15060834

BibTeX
@article{Kushawaha2025,
  author = {Kushawaha, Bhawna and Rem, Tial T and Pelosi, Emanuele},
  title = {Harnessing Microbiome, Bacterial Extracellular Vesicle, and Artificial Intelligence for Polycystic Ovary Syndrome Diagnosis and Management},
  journal = {Biomolecules},
  year = {2025},
  volume = {15},
  number = {6},
  pages = {834},
  doi = {10.3390/biom15060834}
}
Kostenlos starten →